Johnson & Johnson (ETR:JNJ)

Market Cap	394.52B
Revenue (ttm)	78.81B
Net Income (ttm)	21.48B
Shares Out	n/a
EPS (ttm)	8.85
PE Ratio	18.37
Forward PE	16.84
Dividend	4.62 (2.83%)
Ex-Dividend Date	Aug 26, 2025

Volume	3,518
Average Volume	4,987
Open	162.72
Previous Close	163.34
Day's Range	162.14 - 163.80
52-Week Range	128.16 - 169.62
Beta	0.39
RSI	57.21
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD